Bnp Paribas Asset Management Holding S.A. Bristol Myers Squibb CO Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,931,969 shares of BMY stock, worth $117 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,931,969
Previous 984,246
96.29%
Holding current value
$117 Million
Previous $50.9 Million
114.57%
% of portfolio
0.27%
Previous 0.13%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,764Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.5 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.59 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.8 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.75 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.64 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...